Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (61-70 of 299) with videos related to

Pageof 30
Sort By:
Human Gene Therapy|March 1, 1996
Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancerE M Elder, M T Lotze, T L Whiteside
Current Opinion in Oncology|December 1, 1992
New biologic agents come to bat for cancer therapyM T Lotze, J T Rubin, H J Zeh
Blood|September 25, 2001
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situS Fujii, K Shimizu, T Shimizu, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1986
Intraperitoneal administration of interleukin-2 in patients with cancerM T Lotze, M C Custer, S A Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Rapid extracellular degradation of synthetic class I peptides by human dendritic cellsA A Amoscato, D A Prenovitz, M T Lotze
Annals of Internal Medicine|June 1, 1988
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2S A Rosenberg, M T Lotze, J J Mulé
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980
In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cellsM T Lotze, J L Strausser, S A Rosenberg
Methods in Molecular Medicine|February 5, 2014
Methods for generation of genetically modified fibroblasts for immunotherapy of cancerE M Elder, M T Lotze, T L Whiteside
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigensE A Wiebke, S A Rosenberg, M T Lotze
Digestive Diseases and Sciences|December 1, 1994
"Pseudo-pseudotumor" of the liver. Adenocarcinoma presenting as an inflammatory pseudotumorR E Schwarz, J C Reynolds, M T Lotze
Pageof 30

Showing results (61-70 of 299) with videos related to

Sort By:
Pageof 30
Human Gene Therapy|March 1, 1996
Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancerE M Elder, M T Lotze, T L Whiteside
Current Opinion in Oncology|December 1, 1992
New biologic agents come to bat for cancer therapyM T Lotze, J T Rubin, H J Zeh
Blood|September 25, 2001
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situS Fujii, K Shimizu, T Shimizu, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1986
Intraperitoneal administration of interleukin-2 in patients with cancerM T Lotze, M C Custer, S A Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Rapid extracellular degradation of synthetic class I peptides by human dendritic cellsA A Amoscato, D A Prenovitz, M T Lotze
Annals of Internal Medicine|June 1, 1988
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2S A Rosenberg, M T Lotze, J J Mulé
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980
In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cellsM T Lotze, J L Strausser, S A Rosenberg
Methods in Molecular Medicine|February 5, 2014
Methods for generation of genetically modified fibroblasts for immunotherapy of cancerE M Elder, M T Lotze, T L Whiteside
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigensE A Wiebke, S A Rosenberg, M T Lotze
Digestive Diseases and Sciences|December 1, 1994
"Pseudo-pseudotumor" of the liver. Adenocarcinoma presenting as an inflammatory pseudotumorR E Schwarz, J C Reynolds, M T Lotze
Pageof 30